login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
NEVRO CORP (NVRO) Stock News
USA
- NYSE:NVRO -
US64157F1030
-
Common Stock
5.84
USD
0 (0%)
Last: 4/2/2025, 8:04:00 PM
5.8401
USD
0 (0%)
After Hours:
4/2/2025, 8:04:00 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
NVRO Latest News, Press Relases and Analysis
All
Press Releases
7 months ago - By: Halper Sadeh LLC
- Mentions:
AMPS
PLYA
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AMPS, NVRO, PLYA on Behalf of Shareholders
7 months ago - By: Kahn Swick & Foti, LLC
NEVRO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Nevro Corp. - NVRO
8 months ago - By: Nevro Corp.
- Mentions:
GMED
Nevro Reports Fourth-Quarter and Full-Year 2024 Financial Results
8 months ago - By: Halper Sadeh LLC
- Mentions:
BRDG
TURN
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BRDG, NVRO, TURN on Behalf of Shareholders
8 months ago - By: Benzinga
Demystifying Nevro: Insights From 11 Analyst Reviews
8 months ago - By: Brodsky & Smith LLC
- Mentions:
SYTA
BRDG
TURN
APO
...
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Siyata Mobile Inc. (Nasdaq - SYTA), Bridge Investment Group Holdings Inc. (NYSE - BRDG), Nevro Corp. (NYSE – NVRO), 180 Degree Capital Corp. (Nasdaq – TURN)
8 months ago - By: Halper Sadeh LLC
- Mentions:
PLYA
TURN
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PLYA, TURN, NVRO on Behalf of Shareholders
10 months ago - By: Benzinga
Where Nevro Stands With Analysts
8 months ago - By: Ademi LLP
Shareholder Alert: The Ademi Firm investigates whether Nevro Corp. is obtaining a Fair Price for its Public Shareholders
8 months ago - By: Halper Sadeh LLC
- Mentions:
TGI
PTMN
SLRN
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NVRO, TGI, PTMN, SLRN on Behalf of Shareholders
8 months ago - By: Halper Sadeh LLC
- Mentions:
AMPS
PLYA
SLRN
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PLYA, SLRN, NVRO, AMPS on Behalf of Shareholders
a year ago - By: Nevro Corp.
Nevro Reports Third-Quarter 2024 Financial Results
8 months ago - By: Kahn Swick & Foti, LLC
NEVRO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Nevro Corp. - NVRO
8 months ago - By: Halper Sadeh LLC
- Mentions:
SLRN
TGI
PTMN
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NVRO, SLRN, TGI, PTMN on Behalf of Shareholders
9 months ago - By: Halper Sadeh LLC
NVRO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Nevro Corp. Is Fair to Shareholders
9 months ago - By: Ademi & Fruchter LLP
Shareholder Alert: Ademi & Fruchter LLP Investigates Whether Nevro Corp. Is Obtaining a Fair Price for Its Public Shareholders
9 months ago - By: Globus Medical
- Mentions:
GMED
Globus Medical to Acquire Nevro Corp. to Expand Treatment Options for Patients
9 months ago - By: Nevro Corp.
Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08
9 months ago - By: Nevro Corp.
Nevro Announces Preliminary Fourth-Quarter and Full-Year 2024 Revenue Results
10 months ago - By: Nevro Corp.
Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08
a year ago - By: Nevro Corp.
New Study Demonstrates Multiple Advantages of Nevro1™, the Novel SI Joint Fusion System by Nevro, in Comparison to Posterolateral and Lateral Approaches
a year ago - By: Nevro Corp.
Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08
a year ago - By: Nevro Corp.
New Data Demonstrates Long-Term Improvements in Pain Intensity with Nevro's High-Frequency Spinal Cord Stimulation Therapy
a year ago - By: Nevro Corp.
Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08
a year ago - By: Nevro Corp.
Nevro to Report Third-Quarter 2024 Financial Results and Host Earnings Conference Call on November 11, 2024
Please enable JavaScript to continue using this application.